Sex Differences and Functional Outcome after Intravenous Thrombolysis

Stroke

Volumn 48, Issue 3, 2017, Pages 699-703

  Spaander, Fianne H ^a   Zinkstok, Sanne M ^a   Baharoglu, Irem M ^a   Gensicke, Henrik ^b   Polymeris, Alexandros ^b   Traenka, Christopher ^b   Hametner, Christian ^c   Ringleb, Peter ^c   Curtze, Sami ^d   Martinez Majander, Nicolas ^d   Aarnio, Karoliina ^d   Nolte, Christian H ^e   Scheitz, Jan F ^e   Leys, Didier ^f   Hochart, Anais ^f   Padjen, Visnja ^g   Kägi, Georg ^h   Pezzini, Alessandro ⁱ   Michel, Patrik ^j   Bill, Olivier ^j   Zini, Andrea ^k   Engelter, Stefan T ^b   Nederkoorn, Paul J ^a   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIV LILLE   (France)

^g CLINICAL CENTER OF SERBIA   (Serbia)

^h Department of Neurology ^*  (Switzerland)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^k Nuovo Ospedale S Agostino   (Italy)

more..

Author keywords

age distribution; female; registries; stroke; thrombolytic therapy

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME; BRAIN ISCHEMIA; COMPLICATION; INTRACRANIAL HEMORRHAGES; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; SEXUAL DEVELOPMENT; STROKE; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; SEX CHARACTERISTICS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 85011256378     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.014739     Document Type: Article

References (26)

1. Arnold M, Halpern M, Meier N, Fischer U, Haefeli T, Kappeler L, et al. Age-dependent differences in demographics, risk factors, co-morbidity, etiology, management, and clinical outcome of acute ischemic stroke. J Neurol. 2008;255:1503-1507. doi: 10.1007/s00415-008-0949-9.
2. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, et al; European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003;34:1114-1119. doi: 10.1161/01. STR.0000068410.07397.D7.
3. Glader EL, Stegmayr B, Norrving B, Terént A, Hulter-Asberg K, Wester PO, et al; Risk-Stroke Collaboration. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003;34:1970-1975. doi: 10.1161/01.STR.0000083534.81284.C5.
4. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62-65. doi: 10.1161/01.STR.0000150515.15576.29.
5. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005;36:1447-1451. doi: 10.1161/01.STR.0000170647.42126.a8.
6. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez- Sabín J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke. 2004;35:486-490. doi: 10.1161/01.STR.0000110219.67054.BF.
7. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915-926. doi: 10.1016/S1474-4422(08)70193-5.
8. Perry A, Wang X, Goldberg R, Ross R, Jackson L. The relationship between cardiometabolic and hemostatic variables: influence of race. Metabolism. 2008;57:200-206. doi: 10.1016/j.metabol.2007.09.001.
9. Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995;91:1952-1958.
10. Kain K, Carter AM, Bamford JM, Grant PJ, Catto AJ. Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke. J Thromb Haemost. 2003;1:390-392.
11. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002;3:433-442. doi: 10.1038/nrn846.
12. Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, et al; SITS Investigators. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Neurology. 2012;78:880-887. doi: 10.1212/ WNL.0b013e31824d966b.
13. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial Stroke. Stroke.1997;28:2119-2125. doi: 10.1161/01.STR.28.11.2119.
14. Putaala J, Metso TM, Metso AJ, Mäkelä E, Haapaniemi E, Salonen O, et al. Thrombolysis in young adults with ischemic stroke. Stroke. 2009;40:2085-2091. doi: 10.1161/STROKEAHA.108.541185.
15. Reuter B, Gumbinger C, Sauer T, Wiethölter H, Bruder I, Diehm C, et al; Stroke Working Group of Baden-Wuerttemberg. Intravenous thrombolysis is effective in young adults: results from the Baden-Wuerttemberg Stroke Registry. Front Neurol. 2015;6:229. doi: 10.3389/fneur.2015.00229.
16. Engelter ST, Soinne L, Ringleb P, Sarikaya H, Bordet R, Berrouschot J, et al. IV thrombolysis and statins. Neurology. 2011;77:888-895. doi: 10.1212/WNL.0b013e31822c9135.
17. Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013;44:1080-1084. doi: 10.1161/ STROKEAHA.111.000126.
18. Gensicke H, Zinkstok SM, Roos YB, Seiffge DJ, Ringleb P, Artto V, et al. IV thrombolysis and renal function. Neurology. 2013;81:1780-1788. doi: 10.1212/01.wnl.0000435550.83200.9e.
19. Gensicke H, Strbian D, Zinkstok SM, Scheitz JF, Bill O, Hametner C, et al; Thrombolysis in Stroke Patients (TriSP) Collaborators. Intravenous thrombolysis in patients dependent on the daily help of others before stroke. Stroke. 2016;47:450-456. doi: 10.1161/ STROKEAHA.115.011674.
20. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
21. Shobha N, Sylaja PN, Kapral MK, Fang J, Hill MD; Investigators of the Registry of the Canadian Stroke Network. Differences in stroke outcome based on sex. Neurology. 2010;74:767-771. doi: 10.1212/ WNL.0b013e3181d5275c.
22. Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC; GAIN Americas Investigators. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology. 2007;68:842-848. doi: 10.1212/01.wnl.0000256748.28281.ad.
23. Lorenzano S, Ahmed N, Falcou A, Mikulik R, Tatlisumak T, Roffe C, et al; SITS Investigators. Does sex influence the response to intravenous thrombolysis in ischemic stroke?: answers from safe implementation of treatments in Stroke-International Stroke Thrombolysis Register. Stroke. 2013;44:3401-3406. doi: 10.1161/STROKEAHA.113.002908.
24. Buijs JE, Uyttenboogaart M, Brouns R, de Keyser J, Kamphuisen PW, Luijckx GJ. The effect of age and sex on clinical outcome after intravenous recombinant tissue plasminogen activator treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25:312-316. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.035.
25. Liao S, Chen W, Kuo J, Chen C. Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci Lett. 2001;297:159-162.
26. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409.